% at floor | % at ceiling | Mean (sd) change | SRM | |||
---|---|---|---|---|---|---|
T0 | T1 | T0 | T1 | |||
EQ-5D | ||||||
Overall | 0 | 0 | 23.3 | 23.2 | −0.01 (0.23) | −0.04 |
Health improvement | 0 | 0 | 27.6 | 31.0 | 0.04 (0.22) | 0.18 |
No change | 0 | 0 | 28.7 | 28.6 | −0.01 (0.20) | −0.05 |
Health deterioration | 0 | 0 | 6.2 | 2.8 | −0.07 (0.29) | −0.24 |
SF-6D | ||||||
Overall | 0 | 0 | 2.9 | 1.8 | −0.01 (0.11) | −0.09 |
Health improvement | 0 | 0 | 4.3 | 2.8 | 0.03 (0.12) | 0.25 |
No change | 0 | 0 | 3.5 | 2.3 | −0.01 (0.10) | −0.10 |
Health deterioration | 0 | 0 | 0.4 | 1.2 | −0.03 (0.11) | −0.27 |
DHP-18 (PD) | ||||||
Overall | 0.2 | 0.4 | 29.0 | 28.5 | −0.28 (14.66) | −0.02 |
Health improvement | 0 | 0 | 27.0 | 26.4 | −1.91 (14.87) | −0.13 |
No change | 0 | 0.3 | 33.3 | 32.5 | −0.36 (13.62) | −0.03 |
Health deterioration | 0.8 | 1.2 | 19.3 | 18.0 | 0.86 (16.08) | 0.05 |
DHP-18 (BA) | ||||||
Overall | 0.3 | 0.2 | 13.7 | 13.4 | 0.52 (13.95) | 0.04 |
Health improvement | 0 | 0 | 15.2 | 15.4 | −2.74 (13.96) | −0.20 |
No change | 0 | 0.1 | 15.7 | 15.1 | 0.46 (12.59) | 0.04 |
Health deterioration | 0 | 0.4 | 7.4 | 7.6 | 2.83 (17.01) | 0.17 |
DHP-18 (DE) | ||||||
Overall | 1.3 | 1.0 | 5.3 | 6.2 | −0.48 (16.25) | −0.03 |
Health improvement | 0.5 | 0 | 5.5 | 6.6 | −4.25 (18.57) | −0.23 |
No change | 1.3 | 0.7 | 5.2 | 6.4 | −0.10 (15.33) | −0.01 |
Health deterioration | 1.9 | 2.8 | 5.4 | 4.4 | 1.08 (16.71) | 0.06 |